McKesson Corp (MCK)

152.57
2.39 1.59
NYSE : Services
Prev Close 150.18
Open 149.91
Day Low/High 149.71 / 153.24
52 Wk Low/High 114.53 / 169.29
Volume 1.39M
Avg Volume 1.58M
Exchange NYSE
Shares Outstanding 210.26M
Market Cap 31.20B
EPS 22.90
P/E Ratio 6.79
Div & Yield 1.36 (0.90%)

Latest News

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AEG, BSM, TG Downgrades: ATAX, BRN, BRT, CAKE, DOOR, HIHO, MCK, MRCC, OBAS, TEVA Initiations: SELB, SRTS Read on to get TheStreet Quant Ratings' detailed report:

McKesson Corporation To Present At The Morgan Stanley Global Healthcare Conference

McKesson Corporation To Present At The Morgan Stanley Global Healthcare Conference

McKesson Corporation (NYSE:MCK) today announced that James Beer, the company's executive vice president and chief financial officer, will present at the Morgan Stanley Global Healthcare Conference in New York at 1:30 p.

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection

J&J's Janssen Pharmaceuticals will oppose Florida's use of its drug in a Thursday execution.

Eclipse in the USA: Then and Now

Eclipse in the USA: Then and Now

A video of what's changed in the thirty plus years since the last eclipse

Finding Value in a Pricey Environment

Finding Value in a Pricey Environment

As McKesson shows, not every good company is priced to perfection.

Allscripts Stock Climbs, Cantor Upgrades After McKesson Deal

Allscripts Stock Climbs, Cantor Upgrades After McKesson Deal

Cantor Fitzgerald says Allscripts acquisition of McKesson's Enterprise Information Solutions will provide it material cost saving opportunities.

McKesson Announces Final Voting Results From 2017 Annual Meeting Of Stockholders

McKesson Announces Final Voting Results From 2017 Annual Meeting Of Stockholders

McKesson Corporation (NYSE:MCK) today announced results from its recent proxy vote, available in the Form 8-K filed with the Securities and Exchange Commission.

Teamsters Wary of McKesson's Promise to Split Top Roles

Teamsters Wary of McKesson's Promise to Split Top Roles

It's been a rough week for McKesson.

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

Top Ranking Democrat McCaskill Expands Probe into Opioid Crisis

McCaskill requested that four more drug companies and three drug distributors turn over documents.

Teamsters Mark Victory Against Executive Pay at Drug Titan McKesson

Teamsters Mark Victory Against Executive Pay at Drug Titan McKesson

McKesson faced some opposition at its shareholder meeting from an unconventional activist investor—a labor union.

McKesson Reports Fiscal 2018 First-Quarter Results

McKesson Reports Fiscal 2018 First-Quarter Results

McKesson Corporation (NYSE:MCK) today reported that revenues for the first quarter ended June 30, 2017 were $51.

McKesson Declares Quarterly Dividend July 26, 2017

McKesson Declares Quarterly Dividend July 26, 2017

The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of thirty-four cents per share on Common Stock, a twenty-one percent increase from twenty-eight cents per share in the prior...

McKesson Announces Preliminary Voting Results From 2017 Annual Meeting Of Stockholders

McKesson Announces Preliminary Voting Results From 2017 Annual Meeting Of Stockholders

McKesson Corporation (NYSE:MCK) today announced preliminary voting results from its Annual Meeting of Stockholders, held earlier today in Irving, Texas.

Teamsters to Protest McKesson's Shareholder Meeting Wednesday

Teamsters to Protest McKesson's Shareholder Meeting Wednesday

ISS and Glass, Lewis echo the union's call for management to address the drug distributor's role in the opioid crisis.

UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round

UPS, McKesson, Chegg and More: 'Mad Money' Lightning Round

Here's a look at what Jim Cramer had to say about companies of interest to Mad Money viewers.

Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)

Investors Should Ignore Washington: Cramer's 'Mad Money' Recap (Tuesday 7/18/17)

Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.

McKesson Corporation Fiscal 2018 First Quarter Conference Call Scheduled For July 27, 2017

McKesson Corporation Fiscal 2018 First Quarter Conference Call Scheduled For July 27, 2017

McKesson Corporation (NYSE:MCK) will release financial results for its first fiscal quarter ended June 30, 2017 on Thursday, July 27, 2017, prior to the opening of trading on the New York Stock Exchange.

Bristol Myers Vies to Be King of Immune-Boosting Cancer Drugs with New Trial Update

Bristol Myers Vies to Be King of Immune-Boosting Cancer Drugs with New Trial Update

The trial's success props open doors for exploring new uses for Opdivo's treatment in immunotherapy.

Celgene Enters PD1 Market with BeiGene Deal

Celgene Enters PD1 Market with BeiGene Deal

Celgene acquired the rights to BeiGene's PD-1 checkpoint inhibitor, propelling the biotech giant forward in immuno-oncology research.

McKesson Reaffirms Fiscal 2018 Guidance

McKesson Corporation (NYSE:MCK) today reaffirmed its earnings guidance for the fiscal year ending March 31, 2018 and the underlying key assumptions provided in its press release on May 18, 2017.

McKesson Corporation To Webcast Investor Day

McKesson Corporation (NYSE:MCK) will host an Investor Day in Boston on Wednesday, June 28, 2017, including presentations by John Hammergren, chairman, president and chief executive officer; James Beer, executive vice...

Dems Roast Trump for Leaving Medicare Out of Drug Price Order

Dems Roast Trump for Leaving Medicare Out of Drug Price Order

The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Drug Price Inflation and a Patent Cliff Could Trigger a Wave of Deals in Generic Drugs Space

Generic drugmakers are likely to limit themselves to acquisitions of small- and mid-sized companies in the immediate future because of over-leveraging and turmoil in the executive ranks..

Short Interest Declines 18% For MCK

The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 874,390 share decrease in total short interest for McKesson Corp , to 3,950,969, a decrease of 18.12% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Cramer: You Need 2 Monday Morning Game Plans

Cramer: You Need 2 Monday Morning Game Plans

We really want to shake out the weak hands here.

TheStreet Quant Rating: C+ (Hold)